Healthcare -
Biotechnology - NASDAQ - US
$ 4.45
1.83 %
$ 304 M
Market Cap
-1.95
P/E
OLMA - COST OF REVENUE
Cost of Revenue OLMA - Olema Pharmaceuticals, Inc.
377 K
LAST VALUE
-52.39%
2 YEAR CAGR
114.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR